Get started
Author

Fatema Alrashed

Observed names: Alrashed, Fatema, F Alrashed, alrashed, fatema
Institution: Kuwait University
ORCID: 0000-0003-4020-5978
Observed ORCIDs: 0000-0003-4020-5978, 0000-0002-5825-7701
OpenAlex ID: A5016445054
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis
2024 · Mohammad Shehab, Fatema Alrashed, et al. · Clinical Gastroenterology and Hepatology · 73
PDF
Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis
2021 · Mohammad Shehab, Fatema Alrashed, et al. · BMJ Open Gastroenterology · 63
PDF
Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn’s Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
2022 · Mohammad Shehab, Fatema Alrashed, et al. · Inflammatory Bowel Diseases · 52
Histological Disease Activity as Predictor of Clinical Relapse, Hospitalization, and Surgery in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
2023 · Mohammad Shehab, Sahad Al Akram, et al. · Inflammatory Bowel Diseases · 35
Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials
2023 · Mohammad Shehab, Fatema Alrashed, et al. · Expert Review of Gastroenterology & Hepatology · 28
Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies
2021 · Mohammad Shehab, Fatema Alrashed, et al. · Vaccines · 22
PDF
Network Meta‐Analysis: Comparative Efficacy of Biologics and Small Molecules in the Induction and Maintenance of Remission in Crohn's Disease
2025 · Mohammad Shehab, Fatema Alrashed, et al. · Alimentary Pharmacology & Therapeutics · 19
Comparative Efficacy of Biologics and Small Molecule Therapies in Improving Patient-Reported Outcomes in Ulcerative Colitis: Systematic Review and Network Meta-Analysis
2024 · Mohammad Shehab, Amro Hassan, et al. · Inflammatory Bowel Diseases · 19
Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study
2021 · Mohammad Shehab, Mohamed Abu-Farha, et al. · Journal of Clinical Medicine · 18
PDF
Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis
2021 · Fatema Alrashed, Robert Battat, et al. · BMJ Open Gastroenterology · 18
PDF
Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study)
2024 · Mohammad Shehab, Ahmad Alfadhli, et al. · Frontiers in Pharmacology · 10
PDF
Effectiveness of vedolizumab and ustekinumab as second biologic agent in achieving target outcomes in tumor necrosis factor antagonists experienced patients with inflammatory bowel disease (enroll-ex study)
2023 · Fatema Alrashed, Israa Abdullah, et al. · Frontiers in Pharmacology · 9
PDF
Network Meta‐Analysis: Comparison of Endoscopic Dysplasia Detection Technologies in Inflammatory Bowel Disease
2025 · Mohammad Shehab, Ahmed Al‐Hindawi, et al. · Alimentary Pharmacology & Therapeutics · 8
Biologic Therapies for the Treatment of Post-ileal Pouch Anal Anastomosis Surgery Chronic Inflammatory Disorders: Systematic Review and Meta-analysis
2022 · Mohammad Shehab, Fatema Alrashed, et al. · Journal of the Canadian Association of Gastroenterology · 8
PDF
The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction
2022 · Fatema Alrashed, Najlaa Almutairi, et al. · Healthcare · 7
PDF
Impact of biologics and small molecules for inflammatory bowel disease on COVID ‐19‐related hospitalization and mortality: A systematic review and meta‐analysis
2022 · Fatema Alrashed, Hajer Alasfour, et al. · JGH Open · 7
PDF
Relationship between Ustekinumab trough concentrations and clinical, biochemical and endoscopic outcomes in Crohn’s disease: A multi-center nationwide retrospective study (TARGET STUDY)
2024 · Mohammad Shehab, Israa Abdullah, et al. · Medicine · 6
COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study
2022 · Mohammad Shehab, Fatema Alrashed, et al. · Vaccines · 6
PDF
Comparative Efficacy of Medical Therapies in Reducing the Risk of Postoperative Recurrence in Crohn’s Disease: A Systematic Review and Network Meta-Analysis
2025 · Mohammad Shehab, Omar Alrashed, et al. · Inflammatory Bowel Diseases · 5
Safety and Effectiveness of Multi-Switch Between Adalimumab Originator and Biosimilars: A Multicenter (SUSTAIN) Study
2025 · Mohammad Shehab, Anwar Almajdi, et al. · Journal of Clinical Medicine · 3
PDF
Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational Study
2024 · Mohammad Shehab, Fatema Alrashed, et al. · Vaccines · 3
PDF
Age as a Predictor of Serum Tumor Necrosis Factor Antagonist Drug and Antidrug Antibody Concentrations in Inflammatory Bowel Disease—A Nationwide Cohort Study
2025 · Mohammad Shehab, Fatema Alrashed · Journal of Clinical Medicine · 2
PDF
Impact of tumor necrosis factor antagonist combination and anti-integrin therapies on body mass index in inflammatory bowel disease: A cross-sectional study
2023 · Mohammad Shehab, Ali Alali, et al. · Frontiers in Medicine · 2
PDF
Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients With Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational Study
2022 · Mohammad Shehab, Fatema Alrashed, et al. · Frontiers in Medicine · 2
PDF
Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-Term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study
2022 · Mohammad Shehab, Fatema Alrashed, et al. · Frontiers in Medicine · 2
PDF
Works count: 55
Citation count: 431
H-index: 10
I10-index: 11
Year
Topic
Type